Fractyl Health

📍 Lexington, United States🗓 Founded 2010👥 88 employees💰 Last funded Sep 2014
Biotechnology Research🌐 fractyl.com
Website LinkedIn
Fractyl Health is a leader in creating innovative therapies to address the root cause of type 2 diabetes. We were founded based on groundbreaking research and biological insights showing the key role of the intestine in metabolic control. Our therapies are uniquely designed to target and control this controller for the treatment of metabolic disease. Our lead program, Revita DMR, is a first-in-class procedural therapy that is now in late-stage clinical trials for the treatment of type 2 diabetes. Our team is made up of passionate innovators at the intersection of biology and technology, working to deliver better real-world outcomes for people with metabolic disease. Fractyl is located in Lexington, Mass.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Fractyl Health?
Fractyl Health has 1 investors on record on gritt.io, 1 mid-stage.
When did Fractyl Health last raise funding?
The most recent investment in Fractyl Health recorded on gritt.io was in September 2014.
When was Fractyl Health founded?
Fractyl Health was founded in 2010.
What industry is Fractyl Health in?
Fractyl Health operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Fractyl Health based?
Fractyl Health is headquartered in Lexington, United States.